Latest news with #Solutions
Yahoo
a day ago
- Business
- Yahoo
Here's Why You Should Add Cencora Stock to Your Portfolio Now
Cencora, Inc. COR is well-poised for growth on the back of a robust U.S. Healthcare Solutions business and product launches. However, intense competition is a concern. Shares of this Zacks Rank #2 (Buy) company have risen 29.4% so far this year against the industry's 4.7% decline. The S&P 500 Index has decreased 0.3% in the same time frame. Cencora is one of the world's largest pharmaceutical service companies. It is focused on providing drug distribution and related services to reduce healthcare costs and improve patient outcomes. The company has a market capitalization of $56.05 billion. COR's bottom line is anticipated to improve 12.8% over the next five years. Its earnings beat estimates in each of the trailing four quarters, delivering an average surprise of 6%. Image Source: Zacks Investment Research Strong performance in its U.S. Healthcare Solutions segment, particularly in specialty products and GLP-1 medications, is likely to continue to drive growth in 2025. COR and its peers are expanding into the high-margin sector as demand for medicines treating complex conditions, such as rheumatoid arthritis and cancer, continues to grow. The company posted robust second-quarter fiscal 2025 results, with earnings per share (EPS) of $4.42 (up 16.3% year over year) and revenues of $75.45 billion (up 10.3%). Internationally, revenues rose 5.7% at constant currency, supported by the European and Canadian markets. However, the International segment's operating income declined due to lower operating income at COR's global specialty logistics business, partially offset by an increase in its European distribution business. For fiscal 2025, adjusted EPS is estimated to be in the range of $15.70-$15.95 (up from the previous projection of $15.25-$15.55), indicating growth of 14-16% from the prior-year level. The top line is projected to rise 8-10%. Revenues from the U.S. Healthcare Solutions segment and the International Healthcare Solutions business are estimated to increase 9-11% and 3-4%, respectively. Adjusted operating income is expected to improve 13.5-15.5% for fiscal 2025, up from the earlier guidance of 11.5-13.5%. Cencora also acquired Retina Consultants of America earlier this year, expanding its specialty capabilities beyond oncology. This acquisition complements COR's pharmaceutical-centric strategy, strengthens its Management Services Organization portfolio and positions it well in the growing retina and ophthalmology market. Meanwhile, Cencora's focus on specialty pharmaceuticals remains a significant growth driver. Increasing demand for GLP-1 products and specialty distribution to physicians and health systems support strong revenue momentum. Investments in distribution infrastructure and technology improve logistics support and temperature-sensitive product handling and enhance compliance with regulatory standards. Investments in automation and continuity within COR's European and Canadian businesses ensure resilience and scalability in international markets. Renewed collaborations with Express Scripts and Walgreens strengthen core distribution capabilities and align resources to meet customer needs effectively. Cencora operates in a highly competitive pharmaceutical distribution and related healthcare services market. The generic industry is facing the consolidation of customers and manufacturers, global competitors and regulatory challenges. Higher sales of low-margin GLP-1 products and declining COVID-related revenues compress profit margins. Changes in U.S. healthcare policy, particularly Medicare Part B and D reimbursement reforms, could adversely impact profitability. A goodwill impairment on PharmaLex reflects underperformance in outsourced pharma services due to market pressures. Increasing competition in specialty and biosimilar markets may challenge market share and pricing strategies. Cencora, Inc. price | Cencora, Inc. Quote COR has been witnessing a positive estimate revision trend for fiscal 2025. In the past 60 days, the Zacks Consensus Estimate for earnings has increased from $15.28 to $15.36 per share. The consensus mark for second-quarter fiscal 2025 revenues is pegged at $74.64 billion, indicating a 9.1% improvement from the year-ago reported actuals. The bottom-line estimate is pinned at $4.07, implying year-over-year growth of 7.1%. Some other top-ranked stocks from the same medical industry are GENEDX HOLDINGS WGS, CVS Health CVS and CoDiagnostics CODX. GENEDX, sporting a Zacks Rank #1 (Strong Buy) at present, has an estimated growth rate of 336% for 2025. You can see the complete list of today's Zacks #1 Rank stocks here. WGS' earnings beat estimates in each of the trailing four quarters, delivering an average surprise of 145.82%. WGS' shares have lost 6.1% so far this year. CVS Health, carrying a Zacks Rank #2 at present, has an estimated growth rate of 12.2% for 2025. CVS' earnings surpassed estimates in each of the trailing four quarters, delivering an average surprise of 18.08%. CVS' shares have risen 42% year to date. CoDiagnostics, carrying a Zacks Rank of 2 at present, has an estimated earnings growth rate of 45.2% for 2025. CODX's earnings beat estimates in each of the trailing four quarters, delivering an average surprise of 12.72%. Its shares have lost 61.6% so far this year. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report CVS Health Corporation (CVS) : Free Stock Analysis Report Cencora, Inc. (COR) : Free Stock Analysis Report Co-Diagnostics, Inc. (CODX) : Free Stock Analysis Report GeneDx Holdings Corp. (WGS) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
2 days ago
- Business
- Business Wire
Arrow Electronics Earns Dual Honors as Dell Technologies Partner of the Year
CENTENNIAL, Colo.--(BUSINESS WIRE)--Global technology solutions provider Arrow Electronics has received two prestigious awards from Dell Technologies: 2025 OEM Solutions Partner of the Year and 2025 North America Distributor of the Year. The awards were announced at Dell Technologies World, held in Las Vegas in late May. 'These awards underscore the strength of our partnership with Dell Technologies and our shared commitment to driving innovation and empowering mid-market channel partners,' said Eric Nowak, president of Arrow's global enterprise computing solutions business. 'Arrow's ability to deliver end-to-end services at scale—from product readiness to market acceleration—enables us to create transformative solutions that meet the evolving needs of our customers.' Arrow Electronics' Intelligent Solutions business was honored as the 2025 OEM Solutions Partner of the Year, marking a significant milestone in its partnership with Dell Technologies. Previously recognized in North America for three consecutive years, this year's award underscores Arrow's growing impact in driving next-generation engineered systems worldwide. Through its differentiated technology and services stack, the Arrow-Dell alliance empowers OEMs and ISVs to accelerate innovation and bring cutting-edge products to market faster. Arrow's enterprise computing solutions business was named the 2025 North America Distributor of the Year, celebrating its dedication to driving digital transformation across key technology areas including AI, and significant growth through its community of resellers. Phil Sanginario, CEO of Redesign Group, a global technology and cybersecurity firm and longtime Arrow channel partner said, "Partnering with Arrow has enabled us to accelerate innovation and deliver cutting-edge technology to our customers. With Arrow's support, we've seen significant growth in both revenue and market reach, allowing us to better serve our clients and stay ahead in today's competitive landscape.' The Dell Technologies Partner of the Year Awards honor those organizations that demonstrate exceptional performance, growth, and commitment to delivering innovative technology solutions to customers and that showcase excellence aligned with Dell Technologies' core values. Arrow continues to strengthen its position as a trusted technology partner, empowering businesses to achieve their goals by simplifying the complexities of technology and transformation. To learn more about the Arrow-Dell Technologies collaborations, visit or Arrow Electronics (NYSE: ARW) sources and engineers technology solutions for thousands of leading manufacturers and service providers. With global 2024 sales of $28 billion, Arrow's portfolio enables technology across major industries and markets. Learn more at
Yahoo
20-05-2025
- Automotive
- Yahoo
LexisNexis® U.S. Insurance Demand Meter Shows Steady Momentum with "Sizzling" U.S. Consumer Auto Shopping and "Hot" New Policy Growth
ATLANTA, May 20, 2025 /PRNewswire/ -- After a three-quarter streak of "Nuclear" activity, U.S. consumer auto insurance shopping remained elevated in the first quarter of 2025, according to the latest LexisNexis® Risk Solutions U.S. Insurance Demand Meter. U.S. auto policy shopping growth reached "Sizzling" at 16%, and new policy growth came in "Hot" at 8.4%. Both readings represent a slight cooling from Q4 2024. Key Takeaways Shoppers Stay Active: As of March 31, 2025, 46% of policies-in-force were shopped at least once in the past 12 months. Shopping and New Policy Growth Remain Elevated: Auto insurance shopping grew 16% year-over-year in Q1 2025, while new policy growth reached 8.4%. Tax Season and Tariff Concerns Drive Behavior: Consumer activity was fueled by tax refund-driven shopping and new vehicle purchases, potentially ahead of anticipated tariff impacts. Older Consumers Lead the Charge: Policyholders aged 66 and older were the most active demographic, with year-over-year shopping growth of 19.7%. Key Observations"Macro forces like tax refund season and tariff concerns are helping shape consumers' auto insurance shopping behavior in meaningful ways," said Jeff Batiste, senior vice president and general manager, U.S. auto and home insurance, LexisNexis Risk Solutions. "We also are seeing traditionally stable, high-value customer segments become more active in the market. That underscores a potential need for insurers to re-evaluate how they engage and retain policyholders who may have previously been considered low churn risks." First Quarter Trends Influenced by Direct Channel and Tax SeasonShoppers using the direct channel helped drive first-quarter growth across all age groups, with direct distribution outpacing both independent and exclusive agent channels with a 34% year-over-year increase. Meanwhile, the non-standard market segment saw 30% growth, attributed in part by an influx of uninsured shoppers entering the market with tax refunds in hand. While tax season spurred activity, February's shorter calendar tempered overall momentum. Compared to the Leap Year advantage in Q1 2024, 2025 featured one fewer business day, trimming shopping activity. Still, many regions saw elevated shopping growth, with 10 states reporting increases of 20% or more, including Hawaii (59%), New Jersey (43%), Washington (33%) and Massachusetts (31%). New Policy Growth Gets a Boost from Refunds and Pre-Tariff Vehicle SalesNew policy growth remained solid, supported by March's momentum. LexisNexis Risk Solutions internal analysis points to a combination of tax refund season and increased vehicle sales as drivers of this trend, as consumers looked to get ahead of potential cost impacts from impending tariffs. Notably, states such as Nevada (39%), New Jersey (31%) and New York (30%) reported new policy growth of 20% or higher. Loyalty Slips as Market Dynamics ShiftAs economic pressures and more aggressive marketing strategies converge, auto policy retention continues to decline. Average policy retention dropped to 78% by the end of Q1, down from 83% in early 2022. Today, policies are churning nearly 30% faster than just three years ago, with roughly six million more policies switching hands annually compared to 2021. Perhaps more surprising, historically loyal segments, such as policyholders aged 66 and older and those with 10 and more years of tenure, are now contributing significantly to the uptick in shopping and switching behavior. This shift underscores the potential need for insurers to double down on proactive retention strategies. Older Consumers Top the Charts in Shopping ActivityOlder adults, particularly those 66 and older, became the most active shoppers this quarter, growing nearly 20% year-over-year. Meanwhile, the 26-35 age group saw the lowest growth at just over 13%. Rate sensitivity among older consumers on fixed incomes likely played a key role in older shoppers' increased activity, a noteworthy reversal for what has traditionally been a stable segment. Looking AheadLexisNexis Risk Solutions notes that while the full impact of proposed tariffs may not be felt until later in 2025, those currently in effect are already shaping the market. Consumers may fast-track purchases of vehicles and home goods before prices climb and, as a result, insurers could see a ripple effect across both auto and home policy activity. As these lines of business increasingly influence one another, insurance carriers will need to closely monitor shopping trends and refine their acquisition and retention strategies accordingly. "Carriers are achieving notable underwriting results but continue to face significant retention challenges. Declining retention rates may force carriers to replace lost policies to sustain growth, which could strain their current business models," added Batiste. "Acquiring new business is costly, and these policies often have higher claims frequency than long-standing ones, likely increasing both loss and expense ratios. To help maintain positive underwriting results, carriers should remain disciplined in their underwriting approach." Download the latest U.S. Insurance Demand Meter. LexisNexis U.S. Insurance Demand MeterThe LexisNexis® U.S. Insurance Demand Meter is a quarterly analysis of shopping volume and frequency, new business volume and related data points. LexisNexis Risk Solutions offers this unique market-wide perspective of U.S. consumer shopping and switching behavior based on its analysis of consumer shopping transactions since 2009, representing nearly 90% of the universe of U.S. insurance shopping activity. About LexisNexis Risk SolutionsLexisNexis® Risk Solutions harnesses the power of data, sophisticated analytics platforms and technology solutions to provide insights that help businesses across multiple industries and governmental entities reduce risk and improve decisions to benefit people around the globe. Headquartered in metro Atlanta, Georgia, we have offices throughout the world and are part of RELX (LSE: REL/NYSE: RELX), a global provider of information-based analytics and decision tools for professional and business customers. For more information, please visit and Media Contacts:Annalysce BakerLexisNexis Risk SolutionsPhone: +1 View original content to download multimedia: SOURCE LexisNexis Risk Solutions Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
19-05-2025
- Health
- Yahoo
Air Quality in Schools: Camfil Launches Guide to Improving Academic Experience with Improved IAQ
School air filtration leader Camfil's guide to improving academic success which offers strategies to improve school air quality. Air Quality in Schools Camfil Launches Guide to Improving Academic Experience with Improved IAQ Riverdale, NJ, May 19, 2025 (GLOBE NEWSWIRE) -- Camfil, a global leader in school air filtration solutions, has unveiled a new resource designed to help schools improve indoor air quality (IAQ) and enhance learning outcomes. The guide highlights the critical role of air filtration in student health, cognitive performance, and overall school productivity, as part of Camfil's broader efforts to educate the public about the importance of air quality. Indoor air quality in schools is a crucial yet often overlooked factor in academic performance. The new guide from Camfil outlines the key air quality challenges schools face, including exposure to particulate matter, biological contaminants, mold, and VOCs (volatile organic compounds). It also explores how removing these pollutants from the air can lead to healthier, higher-performing learning environments. "Improving air quality in schools is essential for creating a safe and healthy learning environment for students and staff. One effective way to achieve this is by implementing high-quality air filters," says Mark Davidson, Camfil's Manager of Marketing and Technical Materials, "With concerns about airborne illnesses and environmental contaminants, investing in air filtration systems has become a priority for many schools." Key highlights of the article, Clean Air for Academic Success, include: Identifying common pollutants in school environments and their health impacts. Practical steps for deploying integrated air filtration solutions and standalone units. Real-world case studies showcasing improvements in air quality and student performance. Tips for managing IAQ challenges unique to higher-education institutions. Camfil's IAQ guide introduces actionable strategies for implementing high-quality air filtration systems in schools, emphasizing options such as medical-grade HEPA filters and standalone air purifier units for classrooms without modern HVAC systems. Relying on empirical data alongside their combined decades of experience providing air quality solutions to schools, healthcare facilities, and other commercial buildings, Camfil's team demonstrates how such systems contribute to measurable improvements in air quality, academic success, and long-term health outcomes. Explore Camfil's guide, Clean Air for Academic Success, to learn how schools can create healthier learning environments today. About Camfil About Camfil Clean Air Solutions Camfil USA Air Filters For more than half a century, Camfil has been helping people breathe cleaner air. As a leading manufacturer of premium clean air solutions, we provide commercial and industrial systems for air filtration and air pollution control that improve worker and equipment productivity, minimize energy use, and benefit human health and the environment – so we can all breathe easier. To discover how Camfil USA can help you to protect people, processes and the environment, visit us at ## For media inquiries, please contact: Lynne Laake Camfil USA Air Filters T: 888.599.6620 E: F: Friend Camfil USA on Facebook T: Follow Camfil USA on Twitter Y: Watch Camfil Videos on YouTube L: Follow our LinkedIn Page Attachment Air Quality in Schools Camfil Launches Guide to Improving Academic Experience with Improved IAQError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
19-05-2025
- Business
- Business Wire
ICL Reports First Quarter 2025 Results
TEL AVIV, Israel & ST. LOUIS--(BUSINESS WIRE)-- ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the first quarter ended March 31, 2025. Consolidated sales were $1.8 billion versus $1.7 billion in the prior year. Operating income was $185 million versus $203 million of operating income in the first quarter of last year, with adjusted operating income of $208 million versus $215 million. For the first quarter, net income attributable to shareholders was $91 million versus $109 million in the prior year, with adjusted net income of $110 million compared to $118 million. Adjusted EBITDA was $359 million versus $362 million. Diluted earnings per share were $0.07 versus $0.08 in the first quarter of last year, with adjusted diluted EPS of $0.09 – the same as in the first quarter of last year. 'ICL delivered sequential increases in first quarter sales, adjusted EBITDA and EPS, with results led by our specialties-driven businesses. Our Industrial Products, Phosphate Solutions and Growing Solutions businesses also reported year-over-year growth in sales and EBITDA, generally driven by higher volumes with limited price improvement. For our Potash segment, prices were lower year-over-year, as expected, with supply more heavily weighted toward our annual 2024 contracts with China and India, which are at lower prices than current market rates,' said Elad Aharonson, president and CEO of ICL. 'Looking forward, we expect to benefit from our existing distinctive global presence, as the industry awaits additional clarity regarding global tariff and trade negotiations. We plan to rely on our regionally diversified operations and will also continue to focus on specialties solutions for our global customers on a local basis using local production.' The company reiterates its guidance for full year 2025, with specialties-driven EBITDA of between $0.95 billion to $1.15 billion and Potash sales volumes of between 4.5 million and 4.7 million metric tons. (1a) Key Financials First Quarter 2025 US$M Ex. per share data 1Q'25 1Q'24 Sales $1,767 $1,735 Gross profit $560 $557 Gross margin 32% 32% Operating income $185 $203 Adjusted operating income (1) $208 $215 Operating margin 10% 12% Adjusted operating margin (1) 12% 12% Net income attributable to shareholders $91 $109 Adjusted net income attributable to shareholders (1) $110 $118 Adjusted EBITDA (1) $359 $362 Adjusted EBITDA margin (1) 20% 21% Diluted earnings per share $0.07 $0.08 Diluted adjusted earnings per share (1) $0.09 $0.09 Cash flows from operating activities (2) $165 $292 Expand (1) Adjusted operating income and margin, adjusted net income attributable to shareholders, adjusted EBITDA and margin, and diluted adjusted earnings per share are non-GAAP financial measures. Please refer to the adjustments table and disclaimer. (2) See "Condensed consolidated statements of cash flows (unaudited)" in the appendix below. Expand Industrial Products First quarter 2025 Sales of $344 million vs. $335 million. EBITDA of $76 million vs. $72 million. Year-over-year growth driven by better volumes in flame retardants. Key developments versus prior year Flame retardants: Overall sales increased, with bromine-based product sales up slightly, as higher volumes offset lower prices. Sales of phosphorous-based solutions increased, with higher volumes mainly in Europe and the U.S., and overall higher prices. Both the electronics and construction end-markets remained somewhat soft, in the first quarter. Elemental bromine: Higher volumes drove an increase in sales, offsetting lower market prices. Clear brine fluids: Sales lower, despite solid trends and continued strength in oil and gas demand in the Gulf of America, while competition increased in the Eastern Hemisphere. Specialty minerals: A slight increase in sales was driven by higher volumes and prices for magnesium chloride used in deicing, while there was a decrease in specialty magnesia demand for pharma and food applications. Potash First quarter 2025 Sales of $405 million vs. $423 million. EBITDA of $118 million vs. $124 million. Grain Price Index decreased 12.1% year-over-year, with corn up 9.1%, while rice, soybeans and wheat were down 22.2%, 15.1% and 8.1%, respectively. On a sequential basis, the Grain Price Index increased 1.0%, with corn, soybeans and wheat up 10.5%, 3.3%, 4.5%, respectively, while rice declined 6.8%. Key developments versus prior year Potash price: $300 per ton (CIF). Up 5% sequentially but down 7% year-over-year. ICL continued to fulfill its 2024 annual contracts with China and India, and the prices in these agreements were lower than market rates, which improved as the first quarter progressed. Potash sales volumes: 1,103 thousand metric tons. Increased by 19 thousand metric tons year-over-year, with higher volumes mainly to Brazil and China. ICL Dead Sea Production decreased, with continued operational challenges primarily related to external forces. ICL Iberia Production lower, while efficiency efforts remain on-track. Phosphate Solutions First quarter 2025 Sales of $573 million vs. $559 million. EBITDA of $139 million vs. $131 million. Year-over-year growth driven by strength in commodities, while specialties results were lower but in-line with market dynamics. Key developments versus prior year White phosphoric acid: Sales increased, as strong volume growth in all regions offset lower prices. Industrial phosphates: Sales increased, as higher volumes in all major regions offset lower prices related to decreasing cost inputs. Food phosphates: Despite higher volumes, sales decreased due to lower market prices, which reflected reduced raw material costs. Battery materials: Sales decreased, as higher prices in China were unable to offset lower volumes. In January, ICL signed a strategic agreement with Shenzhen Dynanonic to establish battery materials production in Europe, and in early April, the company formally commissioned its Battery Materials Innovation and Qualification (BMIQ) Center in St. Louis. Commodity phosphates: Overall phosphate prices were stable to higher, as global demand remained firm and as China continued to restrict exports. Growing Solutions First quarter 2025 Sales of $495 million vs. $479 million. EBITDA of $47 million vs. $42 million. Continued focus on innovative, regional solutions helped drive year-over-year growth. Key developments versus prior year Brazil: Sales increased on both higher volumes and prices, however, product mix and exchange rate fluctuations caused a decrease in gross profit. Europe: Sales decreased on lower volumes, but gross profit increased, due to higher prices and improved product mix. North America: Sales increased, with higher volumes – in part due to the 2024 acquisition of Custom Ag Formulators – and slightly higher prices contributing to increased gross profit. Asia: Sales increased, as higher volumes drove higher gross profit. Product trends: Specialty agriculture sales increased on both higher volumes, in Europe, the U.S., China and Brazil, and higher prices – mainly in Brazil. Turf and ornamental sales increased, with turf and landscape experiencing both higher volumes and prices, while ornamental horticulture volumes declined in the U.S. and China. In early April, ICL acquired a leading ag-biologicals company, and this acquisition further advanced the company's stated goal of expanding its Growing Solutions product offerings and to position the business for further growth in new and adjacent end-markets. Financial Items Financing Expenses Net financing expenses for the first quarter of 2025 were $37 million, up versus $35 million in the corresponding quarter of last year. Tax Expenses Reported tax expenses in the first quarter of 2025 were $42 million, reflecting an effective tax rate of 28%, compared to $42 million in the corresponding quarter of last year, reflecting an effective tax rate of 25%. Available Liquidity ICL's available cash resources, which are comprised of cash and deposits, unutilized revolving credit facility, and unutilized securitization, totaled $1,491 million, as of March 31, 2025. Outstanding Net Debt As of March 31, 2025, ICL's net financial liabilities amounted to $1,993 million, an increase of $142 million compared to December 31, 2024. Dividend Distribution In connection with ICL's first quarter 2025 results, the Board of Directors declared a dividend of 4.26 cents per share, or approximately $55 million, versus 4.57 cents per share, or approximately $59 million, in the first quarter of last year. The dividend will be payable on June 18, 2025, to shareholders of record as of June 4, 2025. About ICL ICL Group Ltd. is a leading global specialty minerals company, which creates impactful solutions for humanity's sustainability challenges in the food, agriculture and industrial markets. ICL leverages its unique bromine, potash and phosphate resources, its global professional workforce, and its sustainability focused R&D and technological innovation capabilities, to drive the company's growth across its end markets. ICL shares are dual listed on the New York Stock Exchange and the Tel Aviv Stock Exchange (NYSE and TASE: ICL). The company employs more than 12,000 people worldwide, and its 2024 revenue totaled approximately $7 billion. For more information, visit ICL's website at To access ICL's interactive CSR report, visit You can also learn more about ICL on Facebook, LinkedIn, YouTube, X and Instagram. Guidance (1a) The company only provides guidance on a non-GAAP basis. The company does not provide a reconciliation of forward-looking adjusted EBITDA (non-GAAP) to GAAP net income (loss), due to the inherent difficulty in forecasting, and quantifying certain amounts that are necessary for such reconciliation, in particular, because special items such as restructuring, litigation, and other matters, used to calculate projected net income (loss) vary dramatically based on actual events, the company is not able to forecast on a GAAP basis with reasonable certainty all deductions needed in order to provide a GAAP calculation of projected net income (loss) at this time. The amount of these deductions may be material, and therefore could result in projected GAAP net income (loss) being materially less than projected adjusted EBITDA (non-GAAP). The guidance speaks only as of the date hereof. The company undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law. The company provides guidance for specialties-driven EBITDA, which includes Industrial Products, Growing Solutions and Phosphate Solutions, as the Phosphate Solutions business is now predominantly specialties focused. For the Potash business, the company is providing sales volume guidance. The company believes this information provides greater transparency, as these new metrics are less impacted by fertilizer commodity prices, given the extreme volatility in recent years. Non-GAAP Statement The company discloses in this quarterly report non-IFRS financial measures titled adjusted operating income, adjusted net income attributable to the company's shareholders, diluted adjusted earnings per share, and adjusted EBITDA. Management uses adjusted operating income, adjusted net income attributable to the company's shareholders, diluted adjusted earnings per share, and adjusted EBITDA to facilitate operating performance comparisons from period to period. The company calculates adjusted operating income by adjusting operating income to add certain items, as set forth in the reconciliation table under 'Adjustments to reported operating, and net income (non-GAAP)' below. Certain of these items may recur. The company calculates adjusted net income attributable to the company's shareholders by adjusting net income attributable to the company's shareholders to add certain items, as set forth in the reconciliation table under 'Adjustments to reported operating, and net income (non-GAAP)' below, excluding the total tax impact of such adjustments. The company calculates diluted adjusted earnings per share by dividing adjusted net income by the weighted-average number of diluted ordinary shares outstanding. Adjusted EBITDA is calculated as net income before financing expenses, net, taxes on income, share in earnings of equity-accounted investees, depreciation and amortization, and certain adjustments presented in the reconciliation table under 'Consolidated adjusted EBITDA, and diluted adjusted earnings per share for the periods of activity' below, which were adjusted for in calculating the adjusted operating income. You should not view adjusted operating income, adjusted net income attributable to the company's shareholders, diluted adjusted earnings per share or adjusted EBITDA as a substitute for operating income or net income attributable to the company's shareholders determined in accordance with IFRS, and you should note that the company's definitions of adjusted operating income, adjusted net income attributable to the company's shareholders, diluted adjusted earnings per share, and adjusted EBITDA may differ from those used by other companies. Additionally, other companies may use other measures to evaluate their performance, which may reduce the usefulness of the company's non-IFRS financial measures as tools for comparison. However, the company believes adjusted operating income, adjusted net income attributable to the company's shareholders, diluted adjusted earnings per share, and adjusted EBITDA provide useful information to both management, and investors by excluding certain items that management believes are not indicative of ongoing operations. Management uses these non-IFRS measures to evaluate the company's business strategies and management performance. The company believes these non‑IFRS measures provide useful information to investors because they improve the comparability of financial results between periods and provide for greater transparency of key measures used to evaluate performance. The company presents a discussion in the period-to-period comparisons of the primary drivers of change in the company's results of operations. This discussion is based in part on management's best estimates of the impact of the main trends on the company's businesses. The company has based the following discussion on its financial statements. You should read such discussion together with the company's financial statements. Forward Looking Statements This announcement contains statements that constitute 'forward‑looking statements', many of which can be identified by the use of forward‑looking words such as 'anticipate', 'believe', 'could', 'expect', 'should', 'plan', 'intend', 'estimate', 'strive', 'forecast', 'targets' and 'potential', among others. The company is relying on the safe harbor provided in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, in making such forward-looking statements. Forward‑looking statements appear in a number of places in this announcement and include, but are not limited to, statements regarding the company intent, belief or current expectations. Forward‑looking statements are based on the company management's beliefs and assumptions and on information currently available to the company management. Such statements are subject to risks and uncertainties, and the actual results may differ materially from those expressed or implied in the forward‑looking statements due to various factors, including, but not limited to: Changes in exchange rates or prices compared to those the company is currently experiencing; loss or impairment of business licenses or mineral extractions permits or concessions; volatility of supply and demand and the impact of competition; the difference between actual reserves and the company reserve estimates; natural disasters and cost of compliance with environmental regulatory legislative and licensing restrictions including laws and regulation related to, and physical impacts of climate change and greenhouse gas emissions; failure to "harvest" salt which could lead to accumulation of salt at the bottom of the evaporation Pond 5 in the Dead Sea; disruptions at the company seaport shipping facilities or regulatory restrictions affecting the company ability to export the company products overseas; general market, political or economic conditions in the countries in which the company operates, including tariffs and trade policies; price increases or shortages with respect to the company principal raw materials; delays in termination of engagements with contractors and/or governmental obligations; the inflow of significant amounts of water into the Dead Sea which could adversely affect production at the company plants; labor disputes, slowdowns and strikes involving the company employees; pension and health insurance liabilities; pandemics may create disruptions, impacting the company sales, operations, supply chain and customers; changes to governmental incentive programs or tax benefits, creation of new fiscal or tax related legislation; and/or higher tax liabilities; changes in the company evaluations and estimates, which serve as a basis for the recognition and manner of measurement of assets and liabilities; failure to integrate or realize expected benefits from mergers and acquisitions, organizational restructuring and joint ventures; currency rate fluctuations; rising interest rates; government examinations or investigations; disruption of the company, or the company service providers', information technology systems or breaches of the company, or the company service providers', data security; failure to retain and/or recruit key personnel; inability to realize expected benefits from the company cost reduction program according to the expected timetable; inability to access capital markets on favorable terms; cyclicality of the company businesses; changes in demand for the company fertilizer products due to a decline in agricultural product prices, lack of available credit, weather conditions, government policies or other factors beyond the company control; sales of the company magnesium products being affected by various factors that are not within the company control; the company ability to secure approvals and permits from the authorities in Israel to continue the company phosphate mining operations in Rotem Amfert Israel; volatility or crises in the financial markets; hazards inherent to mining and chemical manufacturing; the failure to ensure the safety of the company workers and processes; litigation, arbitration and regulatory proceedings; exposure to third party and product liability claims; product recalls or other liability claims as a result of food safety and food-borne illness concerns; insufficiency of insurance coverage; closing of transactions, mergers and acquisitions; war or acts of terror and/or political, economic and military instability in Israel and its region; including the current state of war declared in Israel and any resulting disruptions to the company supply and production chains; filing of class actions and derivative actions against the company, its executives and Board members; The company is exposed to risks relating to its current and future activity in emerging markets; and other risk factors discussed under 'Item 3 - Key Information— D. Risk Factors" in the company's Annual Report on Form 20-F for the year ended December 31, 2024, filed with the U.S. Securities and Exchange Commission (the 'SEC') on March 13, 2025 (the 'Annual Report'). Forward-looking statements speak only as of the date they are made, and the company does not undertake any obligation to update them in light of new information or future developments or to release publicly any revisions to these statements in order to reflect later events or circumstances or to reflect the occurrence of unanticipated events. Investors are cautioned to consider these risks and uncertainties and to not place undue reliance on such information. Forward-looking statements should not be read as a guarantee of future performance or results and are subject to risks and uncertainties, and the actual results may differ materially from those expressed or implied in the forward-looking statements. This announcement for the first quarter of 2025 should be read in conjunction with the Annual Report of 2024 published by the company on Form 20-F, as of and for the year ended December 31, 2024, including the description of the events occurring subsequent to the date of the statement of financial position, as filed with the US SEC. Appendix Condensed Consolidated Statements of Financial Position as of (Unaudited) Condensed Consolidated Statements of Cash Flows (Unaudited) Adjustments to Reported Operating and Net Income (non-GAAP) (1) For 2025 and 2024, reflects charges relating to the security situation in Israel. (2) For 2025, reflects expenses related to the fire incident at Ashdod Port. (3) For 2025, reflects provisions for early retirement, due to restructuring at certain sites, as part of the Company's global efficiency plan. (4) For 2025 and 2024, reflects the tax impact of adjustments made to operating income. Expand Consolidated EBITDA for the Periods of Activity $ millions Three-months ended March 31, 2025 March 31, 2024 Net income 106 126 Financing expenses, net 37 35 Taxes on income 42 42 Less: Share in earnings of equity-accounted investees - - Operating income 185 203 Depreciation and amortization 151 147 Adjustments (1) 23 12 Total adjusted EBITDA 359 362 (1) See "Adjustments to Reported Operating and Net income (non-GAAP)" above. Expand Calculation of Segment EBITDA (1) For the first quarter of 2025, Phosphate Specialties accounted for $324 million of segment sales, $39 million of operating income, $12 million of D&A and $51 million of EBITDA, while Phosphate Commodities accounted for $249 million of segment sales, $52 million of operating income, $36 million of D&A and represented $88 million of EBITDA. Expand
